Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Recruiting × HER2-negative Breast Cancer × Clear all

Phase

Phase 2/3 1 Phase 2 1

Status

Unknown 2 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 268 Carcinoma, Non-Small-Cell Lung 253 Prostatic Neoplasms 149 Colorectal Neoplasms 135 Carcinoma, Hepatocellular 128 Neoplasms 121 Leukemia, Myeloid, Acute 113 Lung Neoplasms 99 Squamous Cell Carcinoma of Head and Neck 94 Pancreatic Neoplasms 89 Multiple Myeloma 88 Triple Negative Breast Neoplasms 86 Stomach Neoplasms 83 Recurrence 82 Ovarian Neoplasms 82 Neoplasm Metastasis 76 Lymphoma, Large B-Cell, Diffuse 66 Melanoma 64 Esophageal Neoplasms 61 Sarcoma 60 Rectal Neoplasms 60 Brain Neoplasms 58 Uterine Cervical Neoplasms 57 Precursor Cell Lymphoblastic Leukemia-Lymphoma 56 Head and Neck Neoplasms 55 Glioblastoma 55 Carcinoma, Renal Cell 51 Lymphoma 47 Leukemia, Lymphocytic, Chronic, B-Cell 47 Endometrial Neoplasms 47

Interventions

trastuzumab deruxtecan 1 taxane 1 sacituzumab govitecan 1 liposomal doxorubicin 1 eribulin 1 Vinorelbine 1 Gemcitabine 1 Carboplatin 1 Capecitabine 1 Anthracyclines 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06102824 2024-11-25

ORIENTA

Guangdong Provincial People's Hospital

Phase 2 Recruiting

HER2-negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡